/People

ROGER POMERANTZ

Former Venture Partner at Flagship Pioneering

New York City Metropolitan Area

Find your path to ROGER

Sign up to see every warm intro you have to ROGER

  • Paths you didn't know you had: your email and LinkedIn already hold routes to ROGER. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Roger Pomerantz is a member of the board of directors at 1E Therapeutics and has held roles at Tibotec Pharma, Johnson & Johnson, Merck & Co., and Seres Therapeutics, where he oversaw its NASDAQ IPO. His work has contributed to the development of 14 approved drugs targeting conditions including HIV, HCV, tuberculosis, CMV, and C. difficile, and he has completed over 160 business development, licensing, and partnership transactions across more than 20 therapeutic areas. He previously chaired the FDA's Antiviral Advisory Committee, serves on the Corporate Advisory Board of the Carey Business School at Johns Hopkins University, and has published over 300 papers on HIV and other infectious diseases.

Frequently asked questions

Who is ROGER POMERANTZ?
Roger Pomerantz is a member of the board of directors at 1E Therapeutics and has held roles at Tibotec Pharma, Johnson & Johnson, Merck & Co., and Seres Therapeutics, where he oversaw its NASDAQ IPO. His work has contributed to the development of 14 approved drugs targeting conditions including HIV, HCV, tuberculosis, CMV, and C. difficile, and he has completed over 160 business development, licensing, and partnership transactions across more than 20 therapeutic areas. He previously chaired the FDA's Antiviral Advisory Committee, serves on the Corporate Advisory Board of the Carey Business School at Johns Hopkins University, and has published over 300 papers on HIV and other infectious diseases.

Founder mafias

About this profile. Compiled from public sources — Flagship Pioneering's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights